BOSTON (Reuters) - Wall Street's savviest investors are picking sides on Bill Ackman's new bet on Valeant Pharmaceuticals International Inc , with ...http://feeds.reuters.com/~r/reuters/businessNews/~3/3OIO0hI3Ub0/story01.htm